These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 33927744)
1. Four Novel Prognostic Genes Related to Prostate Cancer Identified Using Co-expression Structure Network Analysis. Feng T; Wei D; Li Q; Yang X; Han Y; Luo Y; Jiang Y Front Genet; 2021; 12():584164. PubMed ID: 33927744 [TBL] [Abstract][Full Text] [Related]
2. Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis. Song ZY; Chao F; Zhuo Z; Ma Z; Li W; Chen G Aging (Albany NY); 2019 Jul; 11(13):4736-4756. PubMed ID: 31306099 [TBL] [Abstract][Full Text] [Related]
3. Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining. Liu K; Chen Y; Feng P; Wang Y; Sun M; Song T; Tan J; Li C; Liu S; Kong Q; Zhang J Front Genet; 2022; 13():854531. PubMed ID: 35360870 [No Abstract] [Full Text] [Related]
4. Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer. Wang W; Wu Q; Mohyeddin A; Liu Y; Liu Z; Ge J; Zhang B; Shi G; Wang W; Wu D; Wang F Comput Math Methods Med; 2022; 2022():5500416. PubMed ID: 36245843 [TBL] [Abstract][Full Text] [Related]
5. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis. Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363 [TBL] [Abstract][Full Text] [Related]
6. High BLM Expression Predicts Poor Clinical Outcome and Contributes to Malignant Progression in Human Cholangiocarcinoma. Du X; Zhang C; Yin C; Wang W; Yan X; Xie D; Zheng X; Zheng Q; Li M; Song Z Front Oncol; 2021; 11():633899. PubMed ID: 33828983 [TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas. Liu S; Wang W; Zhao Y; Liang K; Huang Y Front Oncol; 2020; 10():809. PubMed ID: 32547947 [No Abstract] [Full Text] [Related]
8. Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis. Tang J; Kong D; Cui Q; Wang K; Zhang D; Gong Y; Wu G Front Oncol; 2018; 8():374. PubMed ID: 30254986 [TBL] [Abstract][Full Text] [Related]
9. Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma. Xu WH; Wu J; Wang J; Wan FN; Wang HK; Cao DL; Qu YY; Zhang HL; Ye DW Front Genet; 2019; 10():821. PubMed ID: 31572440 [No Abstract] [Full Text] [Related]
10. Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis. Ma Z; Wang J; Ding L; Chen Y Medicine (Baltimore); 2020 Jul; 99(28):e21158. PubMed ID: 32664150 [TBL] [Abstract][Full Text] [Related]
11. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis. Chi Q; Geng X; Xu K; Wang C; Zhao H Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537629 [TBL] [Abstract][Full Text] [Related]
12. Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis. Wang Y; Chen L; Ju L; Qian K; Liu X; Wang X; Xiao Y Front Oncol; 2019; 9():1030. PubMed ID: 31681575 [TBL] [Abstract][Full Text] [Related]
13. Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental Validation. Sun Z; Mao Y; Zhang X; Lu S; Wang H; Zhang C; Xiao C; Cao Y; Qing Y; Wang Y; Li K Front Cell Dev Biol; 2021; 9():718638. PubMed ID: 34540835 [TBL] [Abstract][Full Text] [Related]
14. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis. Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X Front Physiol; 2018; 9():399. PubMed ID: 29720944 [TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression. Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461 [TBL] [Abstract][Full Text] [Related]
17. Development and Validation of Novel Biomarkers Related to M2 Macrophages Infiltration by Weighted Gene Co-Expression Network Analysis in Prostate Cancer. Xu N; Dong RN; Lin TT; Lin T; Lin YZ; Chen SH; Zhu JM; Ke ZB; Huang F; Chen YH; Xue XY Front Oncol; 2021; 11():634075. PubMed ID: 34268107 [TBL] [Abstract][Full Text] [Related]
18. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489 [TBL] [Abstract][Full Text] [Related]
20. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis. Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]